US: Allergan cuts jobs, lifts profit

Comment on this story

Allergan would cut 1 500 jobs and eliminate another 250 vacant positions as it tried to fend off a hostile takeover from Valeant Pharmaceuticals International, the US-based maker of wrinkle remover Botox said yesterday. The job cuts and further restructuring would lead to savings of about $475 million (R5bn) next year. Canada’s Valeant is leading an $84bn bid for Allergan, which said second-quarter net income rose 18 percent to $417.2m from $352.7m a year earlier. “With continuing strong momentum, Allergan recorded the strongest increase in absolute dollar sales in any quarter in our history, and again delivered sales and earnings per-share growth above the high end of our expectations,” chief executive David Pyott said. – Bloomberg

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines